São Paulo - Delayed Quote BRL

Hapvida Participações e Investimentos S.A. (HAPV3.SA)

3.7800 +0.1600 (+4.42%)
At close: April 26 at 5:07 PM GMT-3
Key Events
Loading Chart for HAPV3.SA
DELL
  • Previous Close 3.6200
  • Open 3.6400
  • Bid 3.7700 x --
  • Ask 3.7800 x --
  • Day's Range 3.6300 - 3.8200
  • 52 Week Range 2.6700 - 5.4200
  • Volume 40,113,300
  • Avg. Volume 66,375,812
  • Market Cap (intraday) 28.328B
  • Beta (5Y Monthly) 0.55
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1000
  • Earnings Date May 9, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 28, 2021
  • 1y Target Est 5.90

Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the health sector in Brazil. The company offers medical and dental insurance plans. It also provides medical and paramedical, laboratory, diagnostic, imaging, and ultrasound services, as well as organizes courses, lectures, seminars, and other events. In addition, the company engages in the administration, advisory, implementation, and sale of individual, family, and collective health care systems and plans; and reimbursement of medical, dental, hospital, and healthcare expenses to its beneficiaries, as well as provides medical and hospital care services. The company operates a network of 49 hospitals, 49 emergency units, 205 clinics, and 178 diagnostic units. The company was founded in 1979 and is based in Fortaleza, Brazil.

ri.hapvida.com.br

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: HAPV3.SA

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HAPV3.SA
15.06%
IBOVESPA
5.71%

1-Year Return

HAPV3.SA
47.66%
IBOVESPA
22.58%

3-Year Return

HAPV3.SA
74.27%
IBOVESPA
4.97%

5-Year Return

HAPV3.SA
35.50%
IBOVESPA
31.04%

Compare To: HAPV3.SA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HAPV3.SA

Valuation Measures

Annual
As of 4/28/2024
  • Market Cap

    28.33B

  • Enterprise Value

    36.19B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.04

  • Price/Book (mrq)

    0.58

  • Enterprise Value/Revenue

    1.32

  • Enterprise Value/EBITDA

    11.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.70%

  • Return on Assets (ttm)

    0.82%

  • Return on Equity (ttm)

    -1.51%

  • Revenue (ttm)

    27.38B

  • Net Income Avi to Common (ttm)

    -739.89M

  • Diluted EPS (ttm)

    -0.1000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7B

  • Total Debt/Equity (mrq)

    30.38%

  • Levered Free Cash Flow (ttm)

    2.29B

Research Analysis: HAPV3.SA

Analyst Price Targets

4.90
5.90 Average
3.7800 Current
7.00 High
 

Earnings

Consensus EPS
 

Company Insights: HAPV3.SA

People Also Watch